Article
U.S. FDA advisers call for new trial of Lilly, Innovent lung cancer drug
Rating:
0.0
Views:
48
Likes:
1
Library:
1
Innovent Biologics Inc and Eli Lilly and Co should be required to conduct a trial of their lung cancer drug that is applicable to the U.S. population, a panel of advisers to the U.S. Food and Drug Administration recommended Thursday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value